Cardiac Biotech Solutions, Inc. (CBSC)
0.0356
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Cardiac Biotech Solutions Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.04M |
| March 31, 2022 | -0.04M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.125M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.0243M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.1255M |
| December 31, 2017 | -0.0007M |
| September 30, 2017 | -0.125M |
| June 30, 2017 | -0.0062M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -0.0005M |
| June 30, 2016 | -0.0001M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vyome Holdings, Inc. | 0.00 |
| Abbott Laboratories | -673.00M |
| AngioDynamics, Inc. | -1.27M |
| Alphatec Holdings, Inc. | -22.72M |
| AtriCure, Inc. | -3.766M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.1918M |
| Cash from Financing (Quarterly) | 0.19M |
| Free Cash Flow | -0.6874M |
| Free Cash Flow Per Share (Quarterly) | -0.0012 |
| Free Cash Flow to Equity (Quarterly) | -0.1818M |
| Free Cash Flow to Firm (Quarterly) | -0.1714M |
| Free Cash Flow Yield | -11.68% |